These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3088785)

  • 1. Du confirmation.
    Schmidt PJ; Klein RE; Sherwood WC
    Transfusion; 1986; 26(4):364-5. PubMed ID: 3088785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A one-step Du test in microplates.
    Epley KM; Severns ML; Kline LM
    Transfusion; 1988; 28(3):233-6. PubMed ID: 3130693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rh-negative donor.
    Contreras M; Knight RC
    Clin Lab Haematol; 1989; 11(4):317-22. PubMed ID: 2514064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of RhD typing and the antiglobulin test in pretransfusion compatibility tests for Taiwanese.
    Lin M; Broadberry RE
    Vox Sang; 1994; 67 Suppl 5():28-9. PubMed ID: 7701822
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of an agglutination micromethod for erythrocyte phenotyping. Importance of improved blood transfusion safety].
    Reviron M; Reviron J
    Rev Fr Transfus Immunohematol; 1980 May; 23(2):131-9. PubMed ID: 6779369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microplate system for ABO and Rh(D) blood grouping.
    Chung A; Birch P; Ilagan K
    Transfusion; 1993 May; 33(5):384-8. PubMed ID: 8110210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quality control in immuno-hematology tests: evaluation and prospects].
    Rouger P; Salmon C
    Rev Fr Transfus Immunohematol; 1984 Apr; 27(2):141-53. PubMed ID: 6431588
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficient and safe definition of the rhesus-negative donor on the olympus PK 7200 without the indirect antiglobulin test for weak D.
    Mertens G; Muylle L
    Vox Sang; 1996; 70(4):237-8. PubMed ID: 9123933
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors.
    Gowland P; Gassner C; Hustinx H; Stolz M; Gottschalk J; Tissot JD; Thierbach J; Maier A; Sigurdardottir S; Still F; Fontana S; Frey BM; Niederhauser C
    Transfus Apher Sci; 2014 Apr; 50(2):163-8. PubMed ID: 24656493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
    Heddle NM; O'Hoski P; Singer J; McBride JA; Ali MA; Kelton JG
    Br J Haematol; 1992 Aug; 81(4):579-84. PubMed ID: 1390245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of DEL phenotype in RhD negative donor population of north India.
    Samir S; Jain A; Marwaha N
    Transfus Apher Sci; 2015 Aug; 53(1):34-7. PubMed ID: 25818997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in transfusion medicine. Testing for Du: con.
    Contreras M; Knight RC
    Transfusion; 1991; 31(3):270-2. PubMed ID: 1900650
    [No Abstract]   [Full Text] [Related]  

  • 13. Results of the DGTI workshop on the evaluation of the reactivity of monoclonal anti-D.
    Sonneborn HH; Darda C; Ernst M; Flegel WA; Helmbold W; Kasulke D; Kühnl P; Mueller-Eckhardt C; Northoff H; Poschmann A
    Beitr Infusionsther; 1992; 30():382-7. PubMed ID: 1284741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895
    [No Abstract]   [Full Text] [Related]  

  • 15. Rho (Du) variants in blood detected only by the Coombs antiglobulin test, and their significance.
    SIMMONS RT; ALBREY JA
    Med J Aust; 1955 Jul; 42(2 3):87-9. PubMed ID: 13244002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of Du factor using Groupamatic. Comparison with manual technics. Report of 203,240 determinations].
    Garretta M; Muller A; Gener J
    Rev Fr Transfus; 1974 Sep; 17(3):211-27. PubMed ID: 4219822
    [No Abstract]   [Full Text] [Related]  

  • 17. Pretransfusion blood group serology. Limited value of the antiglobulin phase of the crossmatch when a careful screening test for unexpected antibodies is performed.
    Heistø H
    Transfusion; 1979; 19(6):761-3. PubMed ID: 118557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crossmatch. A brief historical perspective.
    Oberman HA
    Transfusion; 1981; 21(6):645-51. PubMed ID: 6797110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Limits of routine blood group serology in perinatal diagnosis].
    Wangerin R; Diekamp U
    Beitr Infusionsther; 1990; 26():367-9. PubMed ID: 1703873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for microplate techniques in liquid-phase blood grouping and antibody screening. A Joint Publication of the British Society for Haematology and the British Blood Transfusion Society. BCSH Blood Transfusion Task Force.
    Clin Lab Haematol; 1990; 12(4):437-60. PubMed ID: 2127909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.